Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges - Top-Institutions - MDSpire

Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges

  • By

  • Xiaomei Hu

  • Mingshu Zhou

  • Weimin Kong

  • July 16, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology

  • #2

    University of Milan
    University of Milan

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #3

    European Institute of Oncology
    European Institute of Oncology

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #5

    Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center
    Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham and Women’s Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges

  • by Xiaomei Hu, Mingshu Zhou, Weimin Kong

  • July 16, 2026

Related Content

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients

Functional brain connectivity correlates of pain relief during virtual reality exposure in cancer patients